Casting Versus Flexible Intramedullary Nailing in Displaced Pediatric Forearm Shaft Fractures

July 23, 2021 updated by: Petra Grahn, Helsinki University Central Hospital

Casting Versus Flexible Intramedullary Nailing in Displaced Forearm Shaft Fractures in 7 to 12 Years Old Children: A Study Protocol for a Randomized Controlled Trial

The forearm is the most common fracture location in children, with an increasing incidence. Displaced forearm shaft fractures have traditionally been treated with closed reduction and cast immobilization. Diaphyseal fractures in children have poor remodeling capacity, and malunion can thus cause permanent cosmetic and functional disability. Internal fixation especially with flexible intramedullary nails has gained increasing popularity, without evidence of a better outcome compared to closed reduction and cast immobilization.

Study Overview

Detailed Description

This is a multicenter, randomized superiority trial comparing closed reduction and cast immobilization to flexible intramedullary nails in 7-12 year old children with > 10° of angulation and/or > 10mm of shortening in displaced both bone forearm shaft fractures (AO-pediatric classification: 22D/2.1-5.2). A total of 78 patients with minimum 2 years of expected growth left are randomized in 1:1 ratio to either treatment group. The study has a parallel non-randomized patient preference arm. Both treatments are performed under general anesthesia. In the cast group a long arm cast is applied for 6 weeks. The flexible intramedullary nail group is immobilized in a collar and cuff sling for 4 weeks. Data is collected at baseline and at each follow-up until 1 year.

Primary outcome is 1) PROMIS Pediatric Item Bank v2.0 - Upper Extremity and 2) forearm pronation-supination range of motion at one-year follow-up. Secondary outcomes are Quick DASH, Pediatric pain questionnaire, Cosmetic VAS, wrist range of motion as well as any complications (malunion, delayed union, non-union or deep wound infection, peripheral nerve injury, need for re-intervention during 1-year follow-up) and costs of treatment.

The investigators hypothesize that flexible intramedullary nailing results in a superior outcome.

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Helsinki, Finland, 00029HUS
        • Recruiting
        • HUS New Childrens Hospital
        • Contact:
          • Petra Grahn, MD
          • Phone Number: +358 9 4711
        • Contact:
          • Matti Ahonen, MD
          • Phone Number: + 358 9 4711
      • Kuopio, Finland
        • Recruiting
        • Kuopio University Hospital
        • Contact:
          • Yrjänä Nietosvaara, MD
      • Oulu, Finland
        • Not yet recruiting
        • Oulu University Hospital
        • Contact:
          • Juha-Jaakko Sinikumpu, MD
      • Tampere, Finland
        • Not yet recruiting
        • Tampere University Hospital
        • Contact:
          • Anne Salonen, MD
      • Turku, Finland
        • Recruiting
        • Turku University Hospital
        • Contact:
          • Johanna Syvänen, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 7 to12 year old children
  • Open distal radial physis
  • Both bone forearm shaft fractures (AO-pediatric classification: 22D/2.1-5.2)
  • More than 10 degrees of angulation
  • with or without less than 10mm of shortening

Exclusion Criteria:

  • Patients with bilateral fractures
  • Gustilo-Anderson grade I-III open fracture
  • Neurovascular deficit
  • Compartment syndrome
  • Pathologic fracture
  • Patient not able to give a written informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: FIN (Flexible intramedullary nail)
Fracture reduction and fixation using flexible intramedullary nails. Nails size is 0.4 times the smallest diameter of the medullary canal of radius or ulna measured in radiographs.
Both bone FIN
Active Comparator: Long arm cast
Fractures are reduced under general anesthesia within 3 days from injury and a synthetic circular above elbow cast in neutral pro-supination is applied for six weeks.
Reduction and cast
Other: Patient Choice FIN
Fracture reduction and fixation using flexible intramedullary nails. Nails size is 0.4 times the smallest diameter of the medullary canal of radius or ulna measured in radiographs.
Both bone FIN
Other: Patient Choice cast
Fractures are reduced under general anesthesia within 3 days from injury and a synthetic circular above elbow cast in neutral pro-supination is applied for six weeks.
Reduction and cast

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS Pediatric Item Bank v2.0 - Upper Extremity
Time Frame: 12 months

We aim to confirm that 75 percent of FIN patients have a better PROMIS UE score than what the mean score of the cast patients will be assuming both groups have the same standard deviation.

PROMIS (Patient-Reported Outcomes Measurement Information System) scores are normalized to a mean score of 50, standard deviation of 10, with a theoretical range of 0 to 100. A higher score corresponds to a greater amount of the domain being measured.

12 months
Pro-supination
Time Frame: 12 months
Difference (percent) in forearm pronation-supination range of motion (ROM) at one-year follow-up in comparison to uninjured side.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Disabilities of the Arm, Shoulder and Hand score
Time Frame: 6 weeks, 3, 6 and 12 months
Minimum value is 0 and maximum 100. Higher value indicates worse function. Statistically significant difference in QuickDASH score is 6.8 (18) at 12 months FU.
6 weeks, 3, 6 and 12 months
Measurement Model for the Pediatric Quality of Life Inventory (PedsQL)
Time Frame: 6 weeks, 3, 6 and 12 months
Minimum value is 0 and maximum value is 100. Higher score indicates better health related quality of life.
6 weeks, 3, 6 and 12 months
Measurement Model for the Pediatric Quality of Life Inventory Pediatric Pain Questionaire (PEDS QL PPQ)
Time Frame: 6 weeks, 3, 6 and 12 months
Minimum value 0 maximum value 10. Higher value indicates higher pain intensity
6 weeks, 3, 6 and 12 months
Need for re-interventions
Time Frame: 6 weeks, 3, 6 and 12 months
Minimum value 0 no maximum value. Lower value indicates better outcome.
6 weeks, 3, 6 and 12 months
Rate of participants with malunion
Time Frame: 6 weeks, 3, 6 and 12 months
malunion, delayed union (defined as nonunion at 3 months or later), pseudoarthrosis (defined as 3 cortices out of 4 not united at 6 months or later)
6 weeks, 3, 6 and 12 months
Adverse effects
Time Frame: 6 weeks, 3, 6 and 12 months
adverse effects (wound infection, nerve or/and tendon damage)
6 weeks, 3, 6 and 12 months
Cosmetic VAS
Time Frame: 6 weeks, 3, 6 and 12 months
Minimum value 0 maximum value 10. Higher value indicates better satisfaction
6 weeks, 3, 6 and 12 months
PROMIS Pediatric Item Bank v2.0 - Upper Extremity
Time Frame: 6 weeks, 3, 6 months
Difference between treatment groups
6 weeks, 3, 6 months
Upper limb ROM
Time Frame: 6 weeks, 3, 6 months
Difference (percent) in elbow, wrist flexion extension and pronation-supination in comparison to uninjured side
6 weeks, 3, 6 months
Return to sport/musical instrument and level
Time Frame: 6 weeks, 3, 6 and 12 months
Level of practiced sport or musical instrument before and at end of trial, as well as time from injury to return to hobby is registered.
6 weeks, 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ilkka Helenius, MD, Helsinki University Central Hospital
  • Principal Investigator: Petra Grahn, MD, Helsinki University Central Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Anticipated)

December 31, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

December 6, 2020

First Submitted That Met QC Criteria

December 10, 2020

First Posted (Actual)

December 11, 2020

Study Record Updates

Last Update Posted (Actual)

July 30, 2021

Last Update Submitted That Met QC Criteria

July 23, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 78/1801/2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

All data will be available upon request. Data will be delivered as anonymized.

IPD Sharing Time Frame

Study protocol is published in BMJ open. What can not be found there can be shared by contacting the main investigator.

IPD Sharing Access Criteria

Please see the study protocol in BMJ open

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Both Bone Forearm Fracture

Clinical Trials on Flexible intramedullary nail (FIN)

Subscribe